Aim: The aim of this study was to investigate the effects of 1mT, 1.5 mT, and 2 mT extremely low-frequency magnetic fields, which were within the limits for public environmental and occupational magnetic field exposure guidelines, on apoptosis, neurodegeneration and trace elements in rat brain cells. Material and Method: A total of 35 adult male Wistar rats were allocated into four main groups: Group 1 (n=8) was healthy controls; Group 2 (n=9) was exposed to 1 mT extremely low-frequency magnetic field; Group 3 (n=9) was exposed to 1.5 mT extremely low-frequency magnetic field and Group 4 (n=9) was exposed to 2 mT extremely low-frequency magnetic field. All the rats in the exposure groups were exposed to 50 Hz extremely low-frequency magnetic field for 4 hours per day, 5 days per week for 30 days in the Helmholtz coils. After the exposure, rats were sacrificed and rat brains were evaluated for histopathological and immunohistochemical changes as well as about the trace element levels in the brain. Results: Different levels of exposure to extremely low-frequency magnetic field doses caused increases in Ca levels and increased apoptosis in the rat brain. As the applied extremely low-frequency magnetic field levels increased, so did the apoptosis and Ca levels in the brain tissues. Conclusion: Extremely low-frequency magnetic field exposure caused neurodegeneration in rat brain tissue, increased apoptosis, and increased Ca concentration. These changes may cause various biological damage, especially cancer in healthy tissues and measures should be taken to minimize extremely low-frequency magnetic field exposure in daily life in terms of protecting public health.

This study aimed to investigate the effect of alpha-lipoic acid (ALA) on liver damage caused by extremely low-frequency magnetic fields (ELF-MFs) in rats. Thirty-two male rats were arbitrarily assigned into four groups: Group 1 (control group), Group 2 (ELF-MF exposure group), Group 3 (ELF-MF exposure + ALA administration), and Group 4 (sham group). Groups 2 and 3 were exposed to ELF-MF at 2 mT intensity emitted by two Helmholtz coils for 4 hours/day throughout 30 days. Group 3 received ALA intraperitoneally (100 mg/kg/day) 1 hour prior to each exposure for 30 days. Group 4 was placed inside the coils, but the generator was turned off. Histopathological analysis of the liver revealed statistically significant increases in hyperemia, inflammation, fibrosis, vacuolization, multiple nuclei, and biliary proliferation in Group 2 compared to all other groups. Immunohistochemical evaluation showed that Group 2 had statistically significantly higher TUNEL and caspase-3 levels than all other groups. ELF-MF-induced alterations, including hyperemia, inflammation, vacuolization, and multiple nuclei, were significantly reduced in Group 3 compared with Group 2. However, no significant difference was observed between Group 2 and Group 3 regarding bile duct proliferation or fibrosis. No pathological changes were observed in Groups 1 and 4. ALA administration effectively reduced some histopathological changes caused by ELF-MF, particularly hyperemia, inflammation, vacuolization, and multiple nuclei, but did not improve fibrosis or biliary proliferation. Additionally, it reduced TUNEL and caspase-3 expression. Our findings suggest that ALA exhibits anti-apoptotic and anti-inflammatory effects against ELF-MF-induced liver damage.

A 75-year-old man with a previous history of left nephrectomy for clear cell renal cell carcinoma in remission was underwent ⁶⁸Ga-DOTATATE PET/CT imaging for evaluation of pancreatic body lesion. It showed a mass with intense ⁶⁸Ga-DOTATATE uptake in the pancreatic corpus. During the follow-up of the patient who did not want to undergo surgery, ¹⁸F-FDG PET/CT scan was performed due to the increase in the size of the mass, and mild FDG uptake was detected in the pancreatic corpus lesion, and histopathological examination was confirmed as renal cell carcinoma metastasis.